Targeting of a B7-1 (CD80) immunoglobulin G fusion protein to acute myeloid leukemia blasts increases their costimulatory activity for autologous remission T cells.
about
Novel non-viral method for transfection of primary leukemia cells and cell linesThe characterization and role of leukemia cell-derived dendritic cells in immunotherapy for leukemic diseasesIndoleamine 2,3-dioxygenase 1 (IDO1) activity in leukemia blasts correlates with poor outcome in childhood acute myeloid leukemia.Immunological weapons against acute myeloid leukaemia.Issues related to targeted delivery of proteins and peptides.Immunotherapy for myeloid leukemias: current status and future directions.Optimization and limitation of calcium ionophore to generate DCs from acute myeloid leukemic cells.Immunotherapy with histamine dihydrochloride for the prevention of relapse in acute myeloid leukemia.Monocytic AML cells inactivate antileukemic lymphocytes: role of NADPH oxidase/gp91(phox) expression and the PARP-1/PAR pathway of apoptosisInduction of T-cell antitumor immunity and protection against tumor growth by secretion of soluble human CD70 molecules.NKp46 and NKG2D receptor expression in NK cells with CD56dim and CD56bright phenotype: regulation by histamine and reactive oxygen species.CD28 and 41BB Costimulation Enhances the Effector Function of CD19-Specific Engager T Cells.A Targeted Graphene Nanoplatform Carrying Histamine Dihydrochloride for Effective Inhibition of Leukemia-Induced Immunosuppression.In vitro co-stimulation with anti-CD28 synergizes with IL-12 in the generation of T cell immune responses to leukaemic cells; a strategy for ex-vivo generation of CTL for immunotherapy.Down-regulation of cellular vascular endothelial growth factor levels induces differentiation of leukemic cells to functional leukemic-dendritic cells in acute myeloid leukemia.Increased population of CD4(+)CD25(high), regulatory T cells with their higher apoptotic and proliferating status in peripheral blood of acute myeloid leukemia patients
P2860
Q24794695-96037C78-8058-45A8-8FD4-D0061EC8C94CQ26852652-8A58A124-F7C5-442A-A6ED-F8A987E042B2Q33688517-A122B4D7-7A53-4CB1-A1CC-EF9A067A88CEQ34842175-4B70FD4D-8553-47FB-9F29-36B3F56C6B73Q36616311-0BAF20B3-15B2-4155-9957-BD03CD7965E1Q37194498-F2E2C8B2-9746-4C94-83D2-61FC6A928B0CQ37336499-640E6FE2-6189-471C-AD61-150596304C3EQ37810123-8E56C0D5-AD24-45A2-BC50-C43A9FD76294Q39355305-148E5CF6-73E1-41CD-B291-234D97409BB3Q40553790-EC02B023-7094-4258-8CB3-110594B5A82BQ43682837-98225F79-EF5B-401A-9CD8-37A0FB8EF774Q45870963-9B2230CF-178A-414A-8A5C-0DA4B58E663CQ46289938-892ACFE4-A768-4A14-B195-E44B8B8047FAQ52006038-6AE3985C-1586-435A-AB47-381B07518D1AQ53585655-3356A69E-961B-4EDE-900F-3B750E568FC2Q56902500-BFD77D9D-4A5E-45F7-9988-74A1A6AA7D71
P2860
Targeting of a B7-1 (CD80) immunoglobulin G fusion protein to acute myeloid leukemia blasts increases their costimulatory activity for autologous remission T cells.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Targeting of a B7-1 (CD80) imm ...... autologous remission T cells.
@en
Targeting of a B7-1
@nl
type
label
Targeting of a B7-1 (CD80) imm ...... autologous remission T cells.
@en
Targeting of a B7-1
@nl
prefLabel
Targeting of a B7-1 (CD80) imm ...... autologous remission T cells.
@en
Targeting of a B7-1
@nl
P2093
P1433
P1476
Targeting of a B7-1 (CD80) imm ...... r autologous remission T cells
@en
P2093
P304
P356
10.1182/BLOOD.V97.10.3138
P407
P577
2001-05-01T00:00:00Z